Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease

KM Kew, A Seniukovich - Cochrane Database of Systematic …, 2014 - cochranelibrary.com
Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

KF Rabe, S Hurd, A Anzueto, PJ Barnes… - American journal of …, 2007 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is
the fourth leading cause of chronic morbidity and mortality in the United States, and is …

[图书][B] Pierre Bourdieu: key concepts

M Grenfell - 2014 - books.google.com
The French social philosopher Pierre Bourdieu is now recognised as one of the major
thinkers of the twentieth century. In a career of over fifty years, Bourdieu studied a wide …

Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline

GJ Criner, J Bourbeau, RL Diekemper, DR Ouellette… - Chest, 2015 - Elsevier
BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

IA Yang, MS Clarke, EHA Sim… - Cochrane Database of …, 2012 - cochranelibrary.com
Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …

Outcomes for COPD pharmacological trials: from lung function to biomarkers

M Cazzola, W MacNee, FJ Martinez… - European respiratory …, 2008 - Eur Respiratory Soc
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …

Airway and systemic inflammation and decline in lung function in patients with COPD

GC Donaldson, TAR Seemungal, IS Patel, A Bhowmik… - Chest, 2005 - Elsevier
Study objectives Patients with COPD experience lower airway and systemic inflammation,
and an accelerated decline in FEV 1. There is no evidence on whether this inflammation …

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial

R Siva, RH Green, CE Brightling… - European …, 2007 - Eur Respiratory Soc
Evidence suggests that eosinophilic airway inflammation is important in the pathogenesis of
severe chronic obstructive pulmonary disease (COPD) exacerbations. The present authors …

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease–2007 update

DE O'donnell, S Aaron, J Bourbeau… - Canadian …, 2007 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that
is both preventable and treatable. Our understanding of the pathophysiology of this complex …

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease

CE Brightling, S McKenna, B Hargadon, S Birring… - Thorax, 2005 - thorax.bmj.com
Background: An association between the sputum eosinophil count and the response to a 2
week course of prednisolone has previously been reported in patients with chronic …